Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.

Clinics in liver disease - 1 Feb 2018

Carter Danielle, Dieterich Douglas T, Chang Charissa

Abstract excerpt

The number of transplants caused by nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NASH) has been progressively increasing and this is expected to become the most common indication for liver transplant in the United States. Patients with NASH show many features of the metabolic syndrome and, as a result, are at higher risk for postoperative cardiovascular morbidity and mortality. Despite this,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Diabetes Complications
Share to Kidney Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipase

Share to Liver Transplantation

Share to Metabolic Syndrome

Share to Non-alcoholic Fatty Liver Disease

Share to Postoperative Complications

Source

Identifiers

PMID: 29128058
DOI: 10.1016/j.cld.2017.08.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.PMID 29128058Read ↗

Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities.Semantic proximity Read ↗

The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver diseaseSemantic proximity Read ↗

Non-alcoholic fatty liver disease.Semantic proximity Read ↗

Present and future therapeutic strategies in non-alcoholic fatty liver disease.Semantic proximity Read ↗

Pathophysiology of Nonalcoholic SteatohepatitisSemantic proximity Read ↗

Hepatic gene expression in patients with obesity‐related non‐alcoholic steatohepatitisSemantic proximity Read ↗

Noninvasive characterization of graft steatosis after liver transplantation.Semantic proximity Read ↗

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan.Semantic proximity Read ↗

The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis.Semantic proximity Read ↗

Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.Semantic proximity Read ↗

Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice.Semantic proximity Read ↗

PNPLA3 as a liver steatosis risk factor following living‐donor liver transplantation for hepatitis CSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.